News & ViewsNewslettersContactBecome a Research Patient
DHRHealth Institute for Research and Development

Clinical Trial

ACTIV-4A ACUTE: A Multicenter, Adaptive, Randomized, Open Label Controlled Platform Trial of the Safety and Efficacy of Antithrombotic and Additional Strategies in Hospitalized Adults with COVID-19

Study Status:

Not yet active

Contact Information:

(956) 362-2396

Please contact us for more information or to learn if you are eligible to participate.

Study Purpose:

This is a randomized, open label, adaptive platform trial to compare the effectiveness of antithrombotic and additional treatment strategies for prevention of adverse outcomes in COVID-19 positive inpatients.

Information: 

Principal Investigator
Olabiyi Akala, MD
Co-PI
Luis Cantu Jr.
Sponsor
National Center for Advancing Translation Sciences
Type of Trial
Interventional
© 2024 DHR Health Institute for Research & Development | All Rights Reserved | Terms & Conditions | Site By: KangoMedia
chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram